WHO stops tests on Trump-backed drug for Covid-19 use
Geneva
TESTS of hydroxychloroquine, an anti-malaria drug touted by US President Donald Trump, were halted in a World Health Organization (WHO) trial of potential Covid-19 treatments.
The hydroxychloroquine arm of the WHO's Solidarity trial was stopped after advisers concluded that the drug shows no benefit compared to the standard of care in reducing deaths, WHO medical officer Ana Maria Henao-Restrepo said on Wednesday at a briefing in Geneva.
Mr Trump has touted the anti-malarial as a treatment for Covid-19 since the early weeks of the global outbreak, call…
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Decarbonisation schemes are generating hot air
BOJ will hike rates if trend inflation accelerates, says Ueda
India tells spice makers to give details of quality checks after Hong Kong allegations
Eurozone business in services-led bounce in April, PMI survey shows
China’s surging steel exports are inflaming global trade tension
German business activity returns to growth in April, PMI survey shows